Monday, July 22, 2013 9:54:37 PM
Lets Not forget the INSIDER BUYS....
Positron Corporation (the “Company”) is pleased to announce that its CEO, Patrick Rooney and CFO, Corey Conn, have recently invested $1,600,000 in Positron through convertible debentures. These cash investments were made from their own funds and earned independent of their positions or compensation with the Company.
“This capital combined with current and future revenues will be utilized to further advance our integrated end-to-end solution for the nuclear cardiology industry,” stated, Patrick Rooney, CEO, Positron Corporation. “We are confident in Positron’s business model and long-term prospects and we will continue to build and support Positron as it evolves into a dynamic nuclear medicine healthcare company. We are pleased in Positron’s achievements to date and are optimistic of its future success.”
Positron Corporation (the “Company”) is pleased to announce that its CEO, Patrick Rooney and CFO, Corey Conn, have recently invested $1,600,000 in Positron through convertible debentures. These cash investments were made from their own funds and earned independent of their positions or compensation with the Company.
“This capital combined with current and future revenues will be utilized to further advance our integrated end-to-end solution for the nuclear cardiology industry,” stated, Patrick Rooney, CEO, Positron Corporation. “We are confident in Positron’s business model and long-term prospects and we will continue to build and support Positron as it evolves into a dynamic nuclear medicine healthcare company. We are pleased in Positron’s achievements to date and are optimistic of its future success.”
Recent POSC News
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2026 06:04:15 PM
- Positron Corporation Secures Multiple PET-CT Orders from Leading Nuclear Cardiologist Practices • GlobeNewswire Inc. • 02/17/2026 02:25:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/30/2025 09:30:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/17/2025 03:21:59 PM
- Positron Corporation Announces Its Transition to a Reporting SEC Company • GlobeNewswire Inc. • 11/17/2025 02:19:08 PM
- Form 10-12G - Registration of securities [Section 12(g)] • Edgar (US Regulatory) • 11/12/2025 10:04:03 PM
- Positron Corporation Enters Industry Partnership Agreement with MedAxiom • GlobeNewswire Inc. • 10/02/2025 01:15:00 PM
- Positron Corporation Wins Innovation Award in PET-CT Category from Medical Device Network’s Excellence Awards 2025 • GlobeNewswire Inc. • 10/01/2025 01:15:00 PM
